Literature DB >> 28967185

iTRAQ-Based Proteomics Suggests Ephb6 as a Potential Regulator of the ERK Pathway in the Prefrontal Cortex of Chronic Social Defeat Stress Model Mice.

Hua Guo1,2,3, Zhi-Lin Huang4, Wei Wang1,2,3, Shu-Xiao Zhang2,3, Juan Li5,2,3, Ke Cheng5,2,3, Ke Xu1,2,3, Yong He2,3, Si-Wen Gui5,2,3, Peng-Fei Li5,2,3, Hai-Yang Wang5,2,3, Zhi-Fang Dong4, Peng Xie1,5,2,3.   

Abstract

PURPOSE: Major depressive disorder (MDD) is a worldwide concern and devastating psychiatric disease. The World Health Organization claims that MDD leads to at least 11.9% of the global burden of disease. However, the underlying pathophysiology mechanisms of MDD remain largely unknown. EXPERIMENTAL
DESIGN: Herein, we proteomic-based strategy is used to compare the prefrontal cortex (PFC) in chronic social defeat stress (CSDS) model mice with a control group. Based on pooled samples, differential proteins are identified in the PFC proteome using iTRAQ coupled with LC-MS/MS.
RESULTS: Ingenuity Pathway Analysis (IPA) is then followed to predict relevant pathways, with the ephrin receptor signaling pathway selected for further research. Additionally, as the selected key proteins of the ephrin receptor signaling pathway, ephrin type-B receptor 6 (EphB6) and the ERK pathway are validated by Western blotting. CONCLUSION AND CLINICAL RELEVANT: Altogether, increased understanding of the ephrin receptor signaling pathway in MDD is provided, which implicates further investigation of PFC dysfunction induced by CSDS treatment.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  EphB6; chronic social defeat stress; iTRAQ; major depressive disorder; prefrontal cortex

Mesh:

Substances:

Year:  2017        PMID: 28967185     DOI: 10.1002/prca.201700115

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  2 in total

1.  Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression.

Authors:  Yiyun Liu; Haiyang Wang; Siwen Gui; Benhua Zeng; Juncai Pu; Peng Zheng; Li Zeng; Yuanyuan Luo; You Wu; Chanjuan Zhou; Jinlin Song; Ping Ji; Hong Wei; Peng Xie
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222

2.  DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression.

Authors:  Jia-En Wu; Yi-Ying Wu; Chia-Hao Tung; Yao-Tsung Tsai; Hsuan-Yu Chen; Yuh-Ling Chen; Tse-Ming Hong
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.